193 related articles for article (PubMed ID: 9694070)
1. Antineutrophil cytoplasmic antibodies in childhood systemic lupus erythematosus.
Bakkaloglu A; Topaloglu R; Saatçi U; Ozdemir S; Ozen S; Başsoy Y; Beşbaş N
Clin Rheumatol; 1998; 17(3):265-7. PubMed ID: 9694070
[TBL] [Abstract][Full Text] [Related]
2. Antineutrophil cytoplasmic antibodies in patients with systemic lupus erythematosus: prevalence, antigen specificity, and clinical associations.
Manolova I; Dancheva M; Halacheva K
Rheumatol Int; 2001 Jul; 20(5):197-204. PubMed ID: 11518040
[TBL] [Abstract][Full Text] [Related]
3. Antineutrophil cytoplasmic antibodies in systemic lupus erythematosus in childhood.
Faure-Fontenla MA; Rodríguez-Suárez RS; Arias-Velásquez R; García-González JE
J Rheumatol; 1999 Nov; 26(11):2480-1. PubMed ID: 10555913
[TBL] [Abstract][Full Text] [Related]
4. Antibodies in systemic lupus antineutrophil cytoplasmic erythematosus: prevalence, disease activity correlations and organ system associations.
Fauzi AR; Kong NC; Chua MK; Jeyabalan V; Idris MN; Azizah R
Med J Malaysia; 2004 Aug; 59(3):372-7. PubMed ID: 15727383
[TBL] [Abstract][Full Text] [Related]
5. Anti-neutrophil cytoplasmic antibody in patients with systemic lupus erythematosus is unrelated to clinical features.
Nishiya K; Chikazawa H; Nishimura S; Hisakawa N; Hashimoto K
Clin Rheumatol; 1997 Jan; 16(1):70-5. PubMed ID: 9132329
[TBL] [Abstract][Full Text] [Related]
6. A critical evaluation of commercial immunoassays for antineutrophil cytoplasmic antibodies directed against proteinase 3 and myeloperoxidase in Wegener's granulomatosis and microscopic polyangiitis.
Csernok E; Ahlquist D; Ullrich S; Gross WL
Rheumatology (Oxford); 2002 Nov; 41(11):1313-7. PubMed ID: 12422006
[TBL] [Abstract][Full Text] [Related]
7. Contribution of immunofluorescence to the identification and characterization of anti-neutrophil cytoplasmic autoantibodies. The role of different fixatives.
Radice A; Vecchi M; Bianchi MB; Sinico RA
Clin Exp Rheumatol; 2000; 18(6):707-12. PubMed ID: 11138332
[TBL] [Abstract][Full Text] [Related]
8. Antineutrophil cytoplasmic antibodies in systemic lupus erythematosus.
Spronk PE; Bootsma H; Horst G; Huitema MG; Limburg PC; Tervaert JW; Kallenberg CG
Br J Rheumatol; 1996 Jul; 35(7):625-31. PubMed ID: 8670594
[TBL] [Abstract][Full Text] [Related]
9. Antigenic specificity of anti-neutrophil cytoplasmic antibody.
Fu HL; Hsu TC; Chang CC; Tsay GJ
J Formos Med Assoc; 2001 Jan; 100(1):35-9. PubMed ID: 11265258
[TBL] [Abstract][Full Text] [Related]
10. A comparison of commercial and in-house ELISAs for antineutrophil cytoplasmic antibodies directed against proteinase 3 and myeloperoxidase.
Pollock W; Dunster K; Rolland JM; Koh H; Savige J
Pathology; 1999 Feb; 31(1):38-43. PubMed ID: 10212921
[TBL] [Abstract][Full Text] [Related]
11. Detection rate and antigenic specificities of antineutrophil cytoplasmic antibodies in chinese patients with clinically suspected vasculitis.
Xin G; Zhao MH; Wang HY
Clin Diagn Lab Immunol; 2004 May; 11(3):559-62. PubMed ID: 15138182
[TBL] [Abstract][Full Text] [Related]
12. [Prevalence and specificity of antineutrophil cytoplasmic antibodies (ANCA) in connective tissue diseases].
Puszczewicz M; Zimmermann-Górska I; Białkowska-Puszczewicz G; Tuchocka A
Pol Arch Med Wewn; 2003 Jan; 109(1):35-41. PubMed ID: 12879764
[TBL] [Abstract][Full Text] [Related]
13. Anti-neutrophil cytoplasmic antibodies (ANCA) in systemic lupus erythematosus: prevalence, clinical associations and correlation with other autoantibodies.
Pradhan VD; Badakere SS; Bichile LS; Almeida AF
J Assoc Physicians India; 2004 Jul; 52():533-7. PubMed ID: 15645975
[TBL] [Abstract][Full Text] [Related]
14. Anti-neutrophil cytoplasmic antibodies in 566 European patients with systemic lupus erythematosus: prevalence, clinical associations and correlation with other autoantibodies. European Concerted Action on the Immunogenetics of SLE.
Galeazzi M; Morozzi G; Sebastiani GD; Bellisai F; Marcolongo R; Cervera R; De Ramòn Garrido E; Fernandez-Nebro A; Houssiau F; Jedryka-Goral A; Mathieu A; Papasteriades C; Piette JC; Scorza R; Smolen J
Clin Exp Rheumatol; 1998; 16(5):541-6. PubMed ID: 9779300
[TBL] [Abstract][Full Text] [Related]
15. Indirect immunofluorescence (IIF) of normal washed peripheral blood cells to demonstrate antineutrophil cytoplasmic antibodies (ANCA).
Paspaliaris B; Pamio M; Savige J
J Clin Pathol; 2000 Oct; 53(10):774-7. PubMed ID: 11064672
[TBL] [Abstract][Full Text] [Related]
16. Level and avidity of antineutrophil cytoplasmic antibodies specific to lactoferrin are useful biomarkers in systemic lupus erythematosus.
Gajic-Veljic M; Lekic B; Nikolic M; Lalosevic J; Stojimirovic B; Bonaci-Nikolic B
Clin Rheumatol; 2022 Mar; 41(3):709-720. PubMed ID: 34618258
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of antineutrophil cytoplasmic antibodies in a large inception cohort of patients with connective tissue disease.
Merkel PA; Polisson RP; Chang Y; Skates SJ; Niles JL
Ann Intern Med; 1997 Jun; 126(11):866-73. PubMed ID: 9163287
[TBL] [Abstract][Full Text] [Related]
18. Comparison of eight commercial kits for quantitation of antineutrophil cytoplasmic antibodies (ANCA).
Wang G; Csernok E; de Groot K; Gross WL
J Immunol Methods; 1997 Oct; 208(2):203-11. PubMed ID: 9433475
[TBL] [Abstract][Full Text] [Related]
19. Atypical ANCA pattern with simultaneous presence of MPO and PR3-ANCA in systemic lupus erythematosus.
Chhabra S; Minz RW; Goyal L; Singh S
J Postgrad Med; 2010; 56(3):217-8. PubMed ID: 20739771
[No Abstract] [Full Text] [Related]
20. Antineutrophil cytoplasmic antibodies in systemic lupus erythematosus.
Pauzner R; Urowitz M; Gladman D; Gough J
J Rheumatol; 1994 Sep; 21(9):1670-3. PubMed ID: 7799347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
